Hoth Therapeutics regains Nasdaq compliance on minimum bid price requirement

Hoth Therapeutics, Inc.

Received Nasdaq notice on Jan 23, 2025 that stock closed at or above $1.00 for 10 consecutive business days (Jan 7-22, 2025).
Compliance with Nasdaq Listing Rule 5550(a)(2) achieved; delisting matter closed.
CEO Robb Knie said milestone reinforces commitment to long-term shareholder value.
Company continues advancing its biopharmaceutical pipeline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.